DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 886 filers reported holding DANAHER CORPORATION in Q3 2014. The put-call ratio across all filers is 0.41 and the average weighting 0.5%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $1,468,000 | +18.5% | 17,393 | +20.1% | 0.04% | +20.6% |
| Q1 2017 | $1,239,000 | +106.8% | 14,483 | +88.3% | 0.03% | +126.7% |
| Q4 2016 | $599,000 | -34.5% | 7,690 | -34.1% | 0.02% | -31.8% |
| Q3 2016 | $915,000 | -73.5% | 11,667 | -65.9% | 0.02% | -69.4% |
| Q2 2016 | $3,451,000 | +22.0% | 34,168 | +14.6% | 0.07% | -10.0% |
| Q1 2016 | $2,829,000 | -29.2% | 29,823 | -30.7% | 0.08% | +17.6% |
| Q4 2015 | $3,996,000 | +11.4% | 43,024 | +2.2% | 0.07% | +15.3% |
| Q3 2015 | $3,586,000 | +17.8% | 42,090 | +17.4% | 0.06% | -4.8% |
| Q1 2015 | $3,045,000 | +716.4% | 35,867 | +724.0% | 0.06% | +933.3% |
| Q4 2014 | $373,000 | -84.2% | 4,353 | -86.0% | 0.01% | -87.0% |
| Q3 2014 | $2,364,000 | +8.9% | 31,116 | +12.9% | 0.05% | +35.3% |
| Q2 2014 | $2,170,000 | +76.3% | 27,560 | +67.9% | 0.03% | +126.7% |
| Q1 2014 | $1,231,000 | -44.1% | 16,410 | -42.4% | 0.02% | -37.5% |
| Q4 2013 | $2,201,000 | +109.6% | 28,513 | +88.2% | 0.02% | +84.6% |
| Q3 2013 | $1,050,000 | – | 15,149 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 241,441 | $70,822,000 | 14.94% |
| Defender Capital, LLC. | 143,752 | $42,381,000 | 14.74% |
| Third Point | 2,490,000 | $730,392,000 | 9.51% |
| Riverstone Advisors, LLC | 63,015 | $18,484,000 | 9.49% |
| 11 Capital Partners LP | 96,063 | $28,178,000 | 8.99% |
| Eos Focused Equity Management, L.P. | 34,026 | $9,981,000 | 8.54% |
| CORTLAND ASSOCIATES INC/MO | 187,609 | $55,031,000 | 7.01% |
| Mirova US LLC | 1,242,440 | $364,444,000 | 7.00% |
| Front Street Capital Management, Inc. | 118,397 | $34,729,000 | 6.47% |
| Alphinity Investment Management Pty Ltd | 909,181 | $266,690,000 | 6.21% |